These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 775004)

  • 1. Plasma post-heparin lipolytic activity and triglyceride clearance in uremic and hemodialysis patients and renal allograft recipients.
    Ibels SL; Reardon MF; Nestel PJ
    J Lab Clin Med; 1976 Apr; 87(4):648-58. PubMed ID: 775004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acids.
    Wessel-Aas T; Blomhoff JP; Wirum E; Nilsen T
    Acta Med Scand; 1984; 216(1):75-83. PubMed ID: 6485883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients.
    Chan MK; Persaud J; Varghese Z; Moorhead JF
    Kidney Int; 1984 May; 25(5):812-8. PubMed ID: 6471667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid profiles and lipase activities in children and adolescents with chronic renal failure treated conservatively or with hemodialysis or transplantation.
    Asayama K; Ito H; Nakahara C; Hasegawa A; Kato K
    Pediatr Res; 1984 Aug; 18(8):783-8. PubMed ID: 6382139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the nature and causes of hyperlipidaemia in uraemia, maintenance dialysis and renal transplantation.
    Ibels LS; Simons LA; King JO; Williams PF; Neale FC; Stewart JH
    Q J Med; 1975 Oct; 44(176):601-14. PubMed ID: 1105647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose tissue lipoprotein lipase in chronic hemodialysis: role in plasma triglyceride metabolism.
    Goldberg A; Sherrard DJ; Brunzell JD
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1173-82. PubMed ID: 400739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK; Pasternack A; Vänttinen T; Ehnholm C; Nikkilä EA
    Acta Med Scand; 1978; 204(3):211-8. PubMed ID: 211802
    [No Abstract]   [Full Text] [Related]  

  • 9. Hypertriglyceridemia in patients with chronic renal insufficiency.
    McCosh EJ; Solangi K; Rivers JM; Goodman A
    Am J Clin Nutr; 1975 Sep; 28(9):1036-43. PubMed ID: 1163470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperlipidemia in uremic children: response to peritoneal dialysis and hemodialysis.
    Berger M; James GP; Davis ER; Jasper PM; Brouhard BH; Travis LB; Cunningham RJ
    Clin Nephrol; 1978 Jan; 9(1):19-24. PubMed ID: 343952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase disturbances induced by uremia and hemodialysis.
    Stegmayr B; Olivecrona T; Olivecrona G
    Semin Dial; 2009; 22(4):442-4. PubMed ID: 19708998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic hyperlipoproteinemia: correlation with residual renal function and duration of maintenance hemodialysis.
    Frank W; Rao TK; Manis T; Delano BG; Avram MM; Saxena AK; Carter AC; Friedman EA
    Trans Am Soc Artif Intern Organs; 1977; 23():59-64. PubMed ID: 910386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic uremia, hemodialysis, and renal transplantation on plasma lipids and lipoproteins in man.
    Bagdade J; Casaretto A; Albers J
    J Lab Clin Med; 1976 Jan; 87(1):38-48. PubMed ID: 173766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of plasma lipids to renal function and length of time on maintenance hemodialysis.
    Frank WM; Sreepada Rao TK; Manis T; Delano BG; Avram MM; Saxena AK; Carter AC; Friedman EA
    Am J Clin Nutr; 1978 Oct; 31(10):1886-92. PubMed ID: 707343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decline of postheparin plasma lipoprotein lipase in acromegalic patients.
    Murase T; Yamada N; Ohsawa N; Kosaka K; Morita S; Yoshida S
    Metabolism; 1980 Jul; 29(7):666-72. PubMed ID: 6991860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.
    Goto T; Saika H; Takahashi T; Maeda A; Mune M; Yukawa S
    Kidney Int Suppl; 1999 Jul; 71():S213-5. PubMed ID: 10412779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glucocorticoid-induced hypertiglyceridemia: effects of cortisone acetate on triglyceride secretion rates and post-heparin lipolytic activity in rabbits (author's transl)].
    Mibayashi Y
    Nihon Naibunpi Gakkai Zasshi; 1978 Mar; 54(3):203-18. PubMed ID: 206474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid metabolism in non-uremic and uremic dogs during and after hemodialysis with acetate.
    Morin RJ; Guo LS; Rorke SJ; Davidson WD
    J Dial; 1978; 2(2):113-29. PubMed ID: 681578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.